Mutations in the ligand binding domain of ESR1 lead to ER constitutive activity. ESR1 mutations are associated with acquired endocrine resistance. Cell-free DNA is a good substrate for ESR1 mutation detection. ESR1 mutation analyses have great potential for clinical decision-making.